Journal Article

Emulation of the control cohort of a randomized controlled trial in pediatric kidney transplantation with Real-World Data from the CERTAIN Registry

Topaloğlu, Rezan, Tönshoff, Burkhard, Strologo, Luca Dello, Prytula, Agnieszka, Fichtner, Alexander, Geissbühler, Yvonne, Pape, Lars, König, Jens, Höcker, Britta, Aubrun, Elodie, Kim, Jon Jin, Grinienko, Anna, Brezinski, Jolanda, Bouts, Antonia, Oh, Jun, Sander, Anja, Weber, Lutz T, Sauer, Lukas D, Haffner, Dieter, Krupka, Kai, Patry, Christian, Grenda, Ryszard, Shenoy, Mohan

2023

Overview

BackgroundRandomized controlled trials in pediatric kidney transplantation are hampered by low incidence and prevalence of kidney failure in children. Real-World Data from patient registries could facilitate the conduct of clinical trials by substituting a control cohort. However, the emulation of a control cohort by registry data in pediatric kidney transplantation has not been investigated so far.MethodsIn this multicenter comparative analysis, we emulated the control cohort (n = 54) of an RCT in pediatric kidney transplant patients (CRADLE trial; ClinicalTrials.gov NCT01544491) with data derived from the Cooperative European Paediatric Renal Transplant Initiative (CERTAIN) registry, using the same inclusion and exclusion criteria (CERTAIN cohort, n = 554).ResultsMost baseline patient and transplant characteristics were well comparable between both cohorts. At year 1 posttransplant, a composite efficacy failure end point comprising biopsy-proven acute rejection, graft loss or death (5.8% ± 3.3% vs. 7.5% ± 1.1%, P = 0.33), and kidney function (72.5 ± 24.9 vs. 77.3 ± 24.2 mL/min/1.73 m2P = 0.19) did not differ significantly between CRADLE and CERTAIN. Furthermore, the incidence and severity of BPAR (5.6% vs. 7.8%), the degree of proteinuria (20.2 ± 13.9 vs. 30.6 ± 58.4 g/mol, P = 0.15), and the key safety parameters such as occurrence of urinary tract infections (24.1% vs. 15.5%, P = 0.10) were well comparable.ConclusionsIn conclusion, usage of Real-World Data from patient registries such as CERTAIN to emulate the control cohort of an RCT is feasible and could facilitate the conduct of clinical trials in pediatric kidney transplantation.

• Publisher: Springer Nature B.V
• Subject: Biopsy / Clinical trials / Comparative analysis / Graft rejection / Kidney transplantation / Kidney transplants / Patients / Pediatrics / Proteinuria / Renal failure / Urinary tract